Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-r...

Date 27 September 2015
Event European Cancer Congress 2015
Session Immunotherapy in Cancer II
Topics Cancer Immunology and Immunotherapy
Presenter George, S.